First clinical Experience of Isatuximab Safety and Tolerability in relapsed and refractory Multiple Myeloma (RRMM): Real-world Data from a Compassionate Use Program in Germany

H Salwender, K Wendelin, F Oduncu, C Kimmich, R Naumann, M Kull, H Goldschmidt, M Ehmer, F Brand, C Kiewitz, C Khandanpour

Research output: Contribution to journalpublished Abstract (Journal)peer-review

Original languageEnglish
Pages (from-to)315-316
Number of pages2
JournalOncology Research and Treatment
Publication statusPublished - 2023
Externally publishedYes

Cite this